Blogs

Categories

Select a sub-category to view results

Films and Coatings
Pharmaceutical Packaging Components
Prefillable Systems
Self Injection Devices
Vial Containment Solutions
Washing and Sterilization
Reconstitution and Transfer Systems

Select a sub-category to view results

Analytical Lab Services
Contract Manufacturing
Fill-Finish
Regulatory Support

Select a sub-category to view results

Cell and Gene Therapy Packaging
Drug Development Process
Regulatory Challenges
Transitioning to Combination Products

Select a sub-category to view results

Corporate Development
ESG/Sustainability
One West Team (Employee Culture)
Our Culture of Giving (Philanthropy)
Research and Development

Previous Blogs

By Brian Kenny

三月 14, 2017

Patients rely on drug products to help protect their health and prevent complications. Pharmaceutical manufacturers rely on a drug product’s primary packaging container and delivery system to maintain the drug quality and ensure that their drug is delivered safely and effectively. But like any drug product, there are risks associated with containment and delivery systems.

On February 23, West hosted a training event, “Understanding Risks Associated with Containment and Delivery Systems Across the Biologic Product Lifecycle from Formulation to Commercialization” a joint presentation from West, Patheon and the National Institute for Bioprocessing Research and Training (NIBRT).